1. Home
  2. ACIW vs BLCO Comparison

ACIW vs BLCO Comparison

Compare ACIW & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIW
  • BLCO
  • Stock Information
  • Founded
  • ACIW 1975
  • BLCO 1853
  • Country
  • ACIW United States
  • BLCO Canada
  • Employees
  • ACIW N/A
  • BLCO N/A
  • Industry
  • ACIW EDP Services
  • BLCO Ophthalmic Goods
  • Sector
  • ACIW Technology
  • BLCO Health Care
  • Exchange
  • ACIW Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • ACIW 5.4B
  • BLCO 6.3B
  • IPO Year
  • ACIW 1995
  • BLCO 2022
  • Fundamental
  • Price
  • ACIW $53.84
  • BLCO $17.36
  • Analyst Decision
  • ACIW Buy
  • BLCO Buy
  • Analyst Count
  • ACIW 6
  • BLCO 12
  • Target Price
  • ACIW $49.50
  • BLCO $20.73
  • AVG Volume (30 Days)
  • ACIW 701.4K
  • BLCO 415.5K
  • Earning Date
  • ACIW 02-27-2025
  • BLCO 02-19-2025
  • Dividend Yield
  • ACIW N/A
  • BLCO N/A
  • EPS Growth
  • ACIW 160.38
  • BLCO N/A
  • EPS
  • ACIW 2.12
  • BLCO N/A
  • Revenue
  • ACIW $1,617,813,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • ACIW $11.87
  • BLCO $17.39
  • Revenue Next Year
  • ACIW $6.95
  • BLCO $6.18
  • P/E Ratio
  • ACIW $25.44
  • BLCO N/A
  • Revenue Growth
  • ACIW 13.31
  • BLCO 18.01
  • 52 Week Low
  • ACIW $28.79
  • BLCO $13.16
  • 52 Week High
  • ACIW $59.71
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • ACIW 53.56
  • BLCO 37.48
  • Support Level
  • ACIW $50.30
  • BLCO $17.00
  • Resistance Level
  • ACIW $53.95
  • BLCO $17.50
  • Average True Range (ATR)
  • ACIW 1.39
  • BLCO 0.44
  • MACD
  • ACIW 0.28
  • BLCO 0.00
  • Stochastic Oscillator
  • ACIW 69.84
  • BLCO 33.65

About ACIW ACI Worldwide Inc.

ACI Worldwide Inc develops, markets, and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: